The standard treatment for early-stage oral cavity squamous cell carcinoma (OCSCC) is definitive surgery. A randomized clinical trial 1 of ipsilateral elective vs therapeutic node dissection in cT1-2 patients with OCSCC demonstrated superior survival in the elective dissection group. Another recent analysis 2 linked higher lymph node count to improved survival in all patients with head and neck cancer with heterogeneous clinical nodal presentations. However, the need for extensive neck dissection in cN0 1748  1264  213  995  1221  1017  246  1107   1   1585  1082  156  753  1138  883  199  885   2   1240  793  109  523  902  645  132  652   3   919  595  77  378  666  471  92  443   4   666  430  53  274  482  328  65  304   5   443  296  33  180  301  211  43  196   6   285  194  23  110  185  133  33  120   7   174  115  9  61  119  78  22  61   8   99  59  4  38  67  55  11  33   9   42  26  3  15  26  20  4  13   10   14  6  0  3  2  8  1  4 Proportion Surviving patients with OCSCC remains unclear. We therefore evaluated the survival impact of lymph node count in these patients using the National Cancer Database (NCDB). Letters selected patients who received definitive surgery, and excluded those who received neoadjuvant therapy, died or were lost to follow-up within 3 months of diagnosis or surgery (immortal time bias), had no information on neck nodes, or no neck dissection. The primary end point of the analysis was overall survival (OS), measured from 3 months after surgery to death or lost to follow-up. We investigated the distribution of node counts and its association with OS using restricted cubic spline and maximally selected rank statistics.
3 A cut-off of 24 was selected based on maximally selected rank statistics. We used Kaplan-Meier methods to estimate OS and Cox regressions to examine the association between OS and clinical and/or surgical factors. We examined model discriminative ability using bootstrapping bias-adjusted concordance probability (c-index) 4 and calibration against the Kaplan-Meier estimated survival. The c-index ranges between 0 and 1 (1 means the model predictions are perfectly concordant with the observed outcomes). Internal validation was performed using bootstrapping with 200 replications. All analyses were performed using SAS statistical software (version 9.4, SAS Institute Inc) and R statistical software (version 3.1, the R Foundation for Statistical Computing).
Results | Final analysis included 7811 patients, with a median follow-up of 48.3 months (95% CI, 47.5-49.3) and OS of 92.2 months (95% CI, 87.0-96.2). The median node count was 23 (range, 1-90); 5998 (77%) patients were pN0. Compared with patients who had 24 or more nodes, those with less than 24 nodes were more likely to have a younger age, advanced clinical and/or pathologic categories, negative margins, adjuvant therapy, surgery at an academic facility, and private insurance. Patients with more than 24 nodes had longer OS compared with those who had 24 or fewer nodes in multivariable analyses (HR, 0.82; 95% CI, 0.75-0.88) (Figure) (Table) . Increased age, comorbidity index, stage, and Medicare or Medicaid insurers were associated with increased mortality. Adjuvant radiation was associated with better OS. Similar results were obtained by using nodal cutoffs of 16 and 18 described elsewhere, 2,5 and by analyzing the nodes by quartiles. The mul tivariable adjusted c-index was 0.66. There was no interaction of lymph node count and other covariates.
Discussion | In this analysis, higher nodal yield (>24) was associated with lower mortality in cN0 patients with OCSCC receiving definitive surgery. Because OCSCC is treated primarily by curative surgery, it is imperative to analyze this disease as a separate entity and account for tumor depth of invasion, a crucial prognostic factor. Furthermore, since locoregional recurrent OCSCC patients have poor salvage outcomes, 6 it is appropriate to use a more stringent nodal yield than previously described.
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Limitations. Potential biases of this study include unmeasured confounders, missing data, selection bias, and report- 
